CML Pediatric ITK Response According to Molecular Identification at Diagnosis — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

CML Pediatric ITK Response According to Molecular Identification at Diagnosis — Stella

Recruiting

Back to Chronic Myeloid Leukemia trials

Trial locations(1 site)

France

CHU de Bordeaux, Service Hématologie Biologique, Bordeaux

Key details

Sponsor

University Hospital, Bordeaux

Enrollment target

~88 participants

Started

February 2023

Primary completion

January 2025

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

6 Years – 18 Years

Last updated August 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov